SEC Form 4 · accession 0001144204-18-041779

USANA HEALTH SCIENCES INC · USNA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Myron W Wentz

Director

Period of report

Jul 31, 2018

Accepted (ET)

Aug 2, 2018 · 8:02 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000896264

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Jul 31, 2018	S	100,000	$131.50	D	10,395,614	I	Shares owned of record by Gull Global Limited
Common Stock^F3,F4,F1	Aug 1, 2018	S	15,111	$127.24	D	10,380,503	I	Shares owned of record by Gull Global Limited
Common Stock^F4,F5,F1	Aug 1, 2018	S	4,743	$128.05	D	10,375,760	I	Shares owned of record by Gull Global Limited
Common Stock^F4,F6,F1	Aug 1, 2018	S	1,200	$129.21	D	10,374,560	I	Shares owned of record by Gull Global Limited
Common Stock^F4,F7,F1	Aug 1, 2018	S	2,700	$130.32	D	10,371,860	I	Shares owned of record by Gull Global Limited
Common Stock^F4,F8,F1	Aug 1, 2018	S	1,500	$131.09	D	10,370,360	I	Shares owned of record by Gull Global Limited
Common Stock^F4,F9,F1	Aug 1, 2018	S	108	$132.25	D	10,370,252	I	Shares owned of record by Gull Global Limited
Common Stock^F4,F10,F1	Aug 2, 2018	S	500	$127.68	D	10,369,752	I	Shares owned of record by Gull Global Limited
Common Stock^F4,F11,F1	Aug 2, 2018	S	5,002	$128.78	D	10,364,750	I	Shares owned of record by Gull Global Limited
Common Stock^F4,F12,F1	Aug 2, 2018	S	5,215	$129.94	D	10,359,535	I	Shares owned of record by Gull Global Limited
Common Stock^F4,F13,F1	Aug 2, 2018	S	3,003	$130.86	D	10,356,532	I	Shares owned of record by Gull Global Limited
Common Stock^F4,F14,F1	Aug 2, 2018	S	918	$131.43	D	10,355,614	I	Shares owned of record by Gull Global Limited

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses

F1The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz.
F10Weighted average price. Price range in multiple transactions was $127.30 to $128.25, inclusive.
F11Weighted average price. Price range in multiple transactions was $128.30 to $129.25, inclusive.
F12Weighted average price. Price range in multiple transactions was $129.30 to $130.25, inclusive.
F13Weighted average price. Price range in multiple transactions was $130.30 to $131.20, inclusive.
F14Weighted average price. Price range in multiple transactions was $131.30 to $131.55, inclusive.
F2The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F3Weighted average price. Price range in multiple transactions was $126.70 to $127.65, inclusive.
F4The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth.
F5Weighted average price. Price range in multiple transactions was $127.70 to $128.65, inclusive.
F6Weighted average price. Price range in multiple transactions was $128.80 to $129.75, inclusive.
F7Weighted average price. Price range in multiple transactions was $129.80 to $130.75, inclusive.
F8Weighted average price. Price range in multiple transactions was $130.80 to $131.75, inclusive.
F9Weighted average price. Price range in multiple transactions was $132.25 to $132.30, inclusive.